Stocks

Gap Raises FY2026 GAAP EPS Guidance from $2.83-$2.93 to $3.77-$3.87 vs $2.47 Est

Gap (NYSE:GAP) raises FY2026 GAAP EPS guidance from $2.83-$2.93 to $3.77-$3.87 vs $2.47 analyst estimate..

Ulta Beauty Raises FY 2026 Buyback Plan From $1.5B To $1.8B

Founder Group shares are trading lower after the company announced a 100-for-1 share combination.

Gap Sees Q3 Sales $3.958B-$3.998B vs $3.981B Est

Gap (NYSE:GAP) sees Q3 sales of $3.958 billion-$3.998 billion vs $3.981 billion analyst estimate.

Dolly Parton Life of Philanthropy May Have Kept Singer From Billionaire Status: ‘I Don’t Work for Money, Never Did’

Dolly Parton left a lasting legacy across music, TV, film and entertainment. The singer also leaves behind a lifetime of philanthropy.

Worksport Announces Warrant Inducement Repricing December 2025 Warrants From $2.90 To $0.60/Share For 3,840,421 Shares, Issuing 4,800,526 New Warrants At $0.60/Share; Expects About $2.3M Gross Proceeds

Key Tronic shares are trading lower after the company reported a year-over-year decrease in Q4 sales results. The company announced it will not issue Q1 revenue and earnings guidance due to uncertainty in the timing of new program ramps and macroeconomic uncertainty.

Gap Raises FY2026 Adj EPS Guidance from $2.30-$2.40 to $2.35-$2.45 vs $2.34 Est; Narrows FY2026 Sales Guidance from $15.520B-$15.670B to $15.554B-$15.631B vs $15.531B Est

Gap (NYSE:GAP) raises FY2026 Adj EPS guidance from $2.30-$2.40 to $2.35-$2.45 vs $2.34 analyst estimate. Narrows FY2026 sales outlook from $15.520 billion-$15.670 billion to $15.554 billion-$15.631 billion vs $15.531

Gap Inc. Names Michael Francis President & CEO Of Old Navy Effective Nov. 2

Gap Inc. (NYSE:GAP) today announced the appointment of Michael Francis as President and Chief Executive Officer of Old Navy, effective November 2, 2026. Francis will succeed Haio Barbeito, who will transition from his

Kazia Therapeutics shares are trading lower after the company announced a proposed public offering.

Gap Q2 Adj. EPS $0.52 Beats $0.48 Estimate, Sales $3.651B Miss $3.690B Estimate

Gap (NYSE:GAP) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.48 by 8.33 percent. This is a 8.77 percent decrease over earnings of $0.57 per share from the same period

Founder Group Announces 100-For-1 Share Combination, Effective September 1, 2026

Beginning with the opening of trading on September 1, 2026, the Company's Class A shares of no par value each (the "Class A Shares") will trade on the Nasdaq Capital Market on an adjusted basis, under the

LifeVantage Plans To Not Issue FY27 Outlook Due To Recent CEO Transition

LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced due to the recent transition in the Chief

iTonic Holdings Says CFO Zhixin Li Resigned Effective Immediately; Appoints Simin Tan As CFO

https://www.sec.gov/Archives/edgar/data/1970544/000121390026094376/ea0302677-6k_itonic.htm

GE Vernova Announces Appointment Of Claire McDonough As CFO Effective January 1, 2027

https://www.gevernova.com/news/press-releases/ge-vernova-announces-chief-financial-officer-transition

PagerDuty Raises FY2027 Adj EPS Guidance from $1.27-$1.32 to $1.33-$1.37 vs $1.32 Est; Raises FY2027 Sales Guidance from $488.500M-$496.500M to $491.500M-$496.500M vs $494.220M Est

PagerDuty (NYSE:PD) raises FY2027 Adj EPS guidance from $1.27-$1.32 to $1.33-$1.37 vs $1.32 analyst estimate. Raises FY2027 sales outlook from $488.500 million-$496.500 million to $491.500 million-$496.500 million vs

IM Cannabis Shares Start Trading On 30-For-1 Split Basis

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the

Affirm Expands Its Global Partnership With Shopify To Launch Shop Pay Installments In Australia

Affirm expands its global partnership with Shopify to launch Shop Pay Installments in Australia. Powered exclusively by Affirm, it provides Australians the added flexibility to pay over time with no hidden fees, using

Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight

The global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.

SoFi Technologies' SoFi Plus: Can Paid Membership Drive Growth?

SoFi Technologies relaunched its premium SoFi Plus membership in Q2 2026, reaching 206,000 paid subscribers with $24 million in annualized revenue. The subscription strategy is working, with 25% of subscribers adding additional products. Management aims for 1 million subscribers within a year, implying $120 million in annual revenue. Meanwhile, competitors Robinhood and Chime are expanding their financial services offerings.

Liquidia vs. Insmed: Which Pulmonary Stock Has Better Prospects Now?

Liquidia (LQDA) and Insmed (INSM) are compared as commercial-stage biopharmaceutical companies focused on pulmonary hypertension treatments. LQDA shows impressive commercial momentum with Yutrepia generating $170.4M in Q2 sales and achieving four consecutive profitable quarters, but faces heavy reliance on a single product. INSM offers a more diversified portfolio with Brinsupri's strong launch ($1.25-$1.40B 2026 guidance) and established Arikayce revenue, plus a broader pipeline. While LQDA has outperformed INSM significantly this year (106.9% vs -28.5%), analysts recommend INSM as the more compelling long-term choice due to its diversified revenue base and sustainable growth story.

CBRS vs. AMD: Which Stock Leads the AI Infrastructure Boom?

Cerebras Systems and Advanced Micro Devices are both benefiting from AI infrastructure growth. While AMD offers greater scale, profitability and diversification with Data Center revenues more than doubling, Cerebras appears to have an edge with faster growth expectations, $25.4B in remaining performance obligations, and strong partnerships with OpenAI and AWS. Cerebras expects core revenues to more than triple in 2027, though it remains unprofitable with customer concentration risks.

IPX1031 Named Best Overall 1031 Exchange Company by Fit Small Business for Fifth Consecutive Year

Investment Property Exchange Services, Inc. (IPX1031) has been recognized as the Best Overall 1031 Exchange Company by Fit Small Business for the fifth consecutive year (2022-2026). The recognition highlights IPX1031's nationwide reach, broad exchange capabilities, financial protections, and expertise in facilitating 1031 Qualified Intermediary services.

PRED sets sports trading fees below half the prediction market average

PRED, a peer-to-peer sports prediction exchange, has introduced trading fees averaging 1% for takers and 0% for makers, positioning itself as the lowest-cost option compared to competitors Kalshi (7%) and Polymarket (5%). The platform uses an identical fee calculation formula to competitors but with a lower coefficient of 2.5%, and has expanded football coverage to include La Liga, Champions League, Europa League, and MLS.

Nvidia $100 Billion Historic Quarter Confirms the AI Boom

Nvidia delivered extraordinary Q2 results with 106% YoY revenue growth to $96.2B, 75% gross margins, and $59.7B net income. The company is compared to historical capital-goods suppliers during major investment booms. Unlike the dot-com era's dark fiber overbuild, AI infrastructure appears economically justified with high utilization rates and profitability. At 23.5x forward earnings with a Zacks Rank #2 (Buy), NVDA stock appears attractively valued despite risks from concentrated customer base and massive financing requirements.

UPDATE -- Canada-Japan Support Advances Xanadu and Mitsubishi Chemical Partnership on Quantum Semiconductor Research

Xanadu Quantum Technologies and Mitsubishi Chemical have announced the second phase of their collaboration to advance quantum computing applications in semiconductor fabrication, specifically for extreme ultraviolet (EUV) lithography. The partnership, supported by Canada's National Research Council Industrial Research Assistance Program (NRC IRAP) and Japan's Strategic Innovation Promotion Program (SIP), aims to develop a fault-tolerant quantum computing-ready software pipeline to identify materials that prevent radiation-induced blurring in chip manufacturing.

Ken Burns and PBS LearningMedia Bring Interactive Educational Content for Classrooms to YouTube

Ken Burns and PBS LearningMedia announced the launch of 'Ken Burns in the Classroom' on YouTube, bringing free, curriculum-aligned educational content to teachers and students. The initiative begins with three courses focused on The American Revolution, featuring professionally edited film segments and interactive materials. Additional courses from Burns's extensive filmography will follow in coming weeks.

Tesla Announces Semi Event For September 24. Here's What Investors Need to Know

Tesla is hosting an invite-only Semi truck event on September 24 to celebrate its new factory and showcase production scaling. While Semi sales have been disappointing since 2017, recent momentum from orders like Einride's 500-unit purchase shows potential. However, significant growth depends on autonomous trucking adoption, which McKinsey projects won't take off until 2032. Key barriers include high upfront costs ($350,000 vs. $165,000 for diesel trucks), operator inexperience, and unpredictable operating costs.

Block Pushes Square Further Into Restaurants: Can Growth Accelerate?

Block's Square division is expanding its restaurant business with partnerships like Cascadia Pizza Co., OpenTable, and The Baked Bear. In Q2 2026, Square's food-and-beverage GPV grew 20% and overall gross profit increased 13% to $1.16 billion. Block reported strong profitability with $3.17 billion gross profit and expects $12.51 billion in full-year 2026 gross profit. Competitors PayPal and Adyen are also expanding their payment partnerships in the restaurant and software sectors.

Why Dollar General Stock Is Up Today

Dollar General's stock rose 3.08% after the retailer boosted its full-year profit forecast. The company reported 5.2% net sales growth to $11.3 billion in Q2, driven by store openings and 3.5% same-store sales growth. Higher gas prices are pushing consumers to seek bargains closer to home, benefiting Dollar General's 21,000+ store network. The company raised its full-year same-store sales guidance to 2.5%-2.9% and EPS guidance to $7.80-$8.00, and plans a $700 million stock buyback.

GEE Group Upgraded to Neutral on Direct-Hire Revenue Growth

GEE Group Inc. (JOB) has been upgraded from Underperform to Neutral rating, reflecting improved profitability driven by higher direct-hire revenues and cost reductions. The company maintains a debt-free balance sheet with $20.3 million in cash. However, persistent weakness in contract staffing, uncertain hiring environment, and AI-related disruption continue to limit near-term growth prospects.

XPON Upgraded to Neutral on Energy Expansion Prospects

Expion Energy (XPON) was upgraded from Underperform to Neutral, reflecting new growth opportunities in oil and gas exploration and expanded Forest River battery relationships. However, the company faces headwinds including declining battery sales (down 28.6% YoY), recurring losses, high customer concentration, and liquidity concerns. The company plans to drill an exploratory well in Eastern Louisiana by February 2027 and launch next-generation lithium-ion battery models in H2 2026.

One of California's Largest Community Microgrids to be built in Rural Pescadero, California

WestLight Energy announced completion of funding for a community microgrid project in Pescadero, California, designed to provide electricity resilience to an entire rural town of 700 residents. The project combines $3.5 million from PG&E's Microgrid Incentive Program, up to $4 million from PG&E for grid upgrades, $10 million from WestLight Energy, and $3 million from San Mateo County. Construction is expected to begin in mid-2029 with service starting in mid-2031.

Why Salesforce Stock Is Soaring This Week

Salesforce stock surged 22% this week after beating Q2 2027 earnings expectations with $11.35B in revenue versus $11.32B expected, and posting $4.29 diluted EPS versus $3.27 anticipated. The company raised its fiscal 2027 revenue guidance to $46.1-$46.4B and EPS guidance to $10.21-$10.25, prompting analysts to raise price targets. At 12.1x operating cash flow versus its five-year average of 18.3x, the stock is considered undervalued.

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Stryker announced its participation in the 2026 Wells Fargo Healthcare Conference on September 8, 2026, with CFO Preston Wells and VP of Investor Relations Nick Mead participating in a fireside chat. The company also declared a quarterly dividend of $0.88 per share and reported second quarter 2026 operating results with net sales increasing 9.4% to $6.6 billion.

Nvidia Stock Soars After Q2 Earnings: Is NVDA Still a Buy?

Nvidia surged 7% after delivering blockbuster Q2 earnings with $96.22B revenue (106% YoY growth) and raising FY28 guidance to ~70% growth. The Vera Rubin platform is ramping ahead of schedule with orders from all major hyperscalers. However, gross margins are expected to compress from 75% to 71-72% due to rising memory costs, and the company's massive capital commitments warrant monitoring.

Abercrombie's Shares Rise 36% on Q2 Earnings Beat on Tariff Refunds

Abercrombie & Fitch (ANF) delivered strong second-quarter fiscal 2026 results with record net sales of $1.27 billion (up 5% YoY) and EPS of $4.17, beating consensus estimates. The company marked its 15th consecutive quarter of growth, with both Abercrombie and Hollister brands posting record Q2 sales. ANF raised its fiscal 2026 sales-growth outlook to ~5% and operating margin guidance to 14.5-15%, supported by strong cash flow and $177 million in Q2 share repurchases.

Nvidia's Supply Commitments More Than Doubled to $279 Billion. Here's What It Does to the Stock.

Nvidia doubled its supply commitments to $279 billion, primarily for memory procurement, to secure components for the next several years of AI demand. While gross margins will compress to 71-72% in Q4 fiscal 2028 as the company absorbs memory cost increases, management expects margins to recover to 72-73% in fiscal 2028 as price increases take effect. Despite near-term margin pressure, the company's strong revenue growth (89% YoY guidance) and reasonable valuation support a positive long-term outlook.

Here's Why You Should Retain ZETA Stock in Your Portfolio Now

Zeta Global (ZETA) reported Q2 2026 revenues of $442.8 million, up 43.5% year-over-year with 28% organic growth. The company raised 2026 guidance to $1.82 billion in revenue and $405 million in adjusted EBITDA, marking its 20th consecutive beat-and-raise quarter. However, rising cost of revenues (41% of sales, up 300 basis points) due to higher-cost social channel adoption and agency exposure present margin pressures. The stock holds a Zacks Rank #3 (Hold) rating.

Music Beats Cancer Launches “Thumbs Up for a Cure” to Support the Next Generation of Childhood Cancer Treatments

Music Beats Cancer, a nonprofit supporting cancer-fighting biotechnologies, will host its inaugural 'Thumbs Up for a Cure' event on September 5 at LongHouse Reserve in East Hampton. The event brings together families, biotech innovators, philanthropists, and artists to advance childhood cancer treatments. A unique Kids Q&A will feature children evaluating promising technologies from biotech companies developing treatments for difficult-to-treat pediatric cancers including DIPG.

Datavault AI Inc. Investors Have Until October 5th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role

A class action lawsuit has been filed against Datavault AI Inc. (NASDAQ: DVLT) for allegedly making materially false and misleading statements regarding corporate partnerships, trading volume on its platform, and undisclosed connections to a convicted felon. Investors who purchased securities between September 4, 2024 and October 30, 2025 have until October 5, 2026 to apply as lead plaintiff.

ARS PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ARS Pharmaceuticals and Encourages Investors to Contact the Firm

A class action lawsuit has been filed against ARS Pharmaceuticals (NYSE:SPRY) for allegedly providing misleading statements about expanded insurance coverage for its epinephrine nasal spray product 'neffy' with CVS Caremark. The company reportedly expressed confidence that coverage would begin July 1, 2026, while failing to disclose risks of delays that would impact summer and back-to-school seasons. Investors who purchased ARS securities between March 9 and June 24, 2026 can apply to be lead plaintiff by October 5, 2026.

Bragar Eagel & Squire, P.C. Reminds Blaize Holdings, Inc. Investors to Contact the Firm Regarding Their Rights Before October 5th

A class action lawsuit has been filed against Blaize Holdings, Inc. (NASDAQ: BZAI) in the U.S. District Court for the Central District of California. The lawsuit alleges that Blaize made false and misleading statements regarding announced transactions with unequipped entities, improper revenue recognition, and materially false public statements. Investors who purchased Blaize securities between July 18, 2025 and April 28, 2026 have until October 5, 2026 to apply to be appointed as lead plaintiff.

Archer Aviation vs. Space Exploration Technologies: Which High Flying Stock Is a Better Buy in 2026?

Archer Aviation and SpaceX represent two different aerospace plays with vastly different maturity levels. Archer is pre-commercial with $300K revenue and $618M losses, pursuing FAA certification for eVTOL aircraft. SpaceX generates $18.7B in revenue but reported a $5B net loss in FY2025 due to massive capital requirements. The article concludes SpaceX is the wiser long-term choice despite both companies' negative cash flows, citing SpaceX's established Starlink business and market support versus Archer's high valuation multiples and regulatory uncertainties.

Dan Ives Says the AI Trade Is Only in the "Third Inning." Should Investors Stay Long AI Stocks?

Dan Ives argues the AI revolution is still in early stages, comparing it to the third inning of baseball. The focus is shifting from GPU purchases to monetizing AI across infrastructure, cloud platforms, and software. Companies with real AI revenue, clear ecosystem roles, and strong customer bases are positioned best for long-term growth.

Bloom Energy Is Down 38% From Its High. Forecasts Suggests a $5,000 Investment Now Will Be Worth This Much by August 2027.

Bloom Energy has surged 149% in 2026 but remains 38% below its $351 52-week high. With a median analyst price target of $295, a $5,000 investment could reach approximately $6,782 by August 2027, representing a 35.6% gain. The company benefits from AI-driven demand for on-site power solutions and recently exceeded $1 billion in quarterly revenue for the first time, though analysts caution that future gains may moderate as the company matures.

Why ServiceNow Rallied Today

ServiceNow stock rallied 9.2% following Salesforce's strong earnings report, which alleviated fears of a 'SaaS-pocalypse' from agentic AI. Salesforce reported 10.8% revenue growth, beat EPS estimates by 80%, and showed its AI-infused Agentforce features growing at 210% annualized revenue run rate. Both companies are positioned as platforms that will collaborate with AI rather than be disrupted by it, with Salesforce announcing a partnership with Anthropic called 'Claudeforce.'

Warren Buffett and Greg Abel Quietly Hold a Bigger Percentage of This Company Than Any Other in Berkshire's Portfolio (Hint: It's Not Apple or American Express)

Berkshire Hathaway holds nearly 45% of DaVita, a kidney dialysis healthcare company, representing its largest proportional equity stake—larger than Apple or American Express. Despite recent modest sell-offs in 2025, DaVita has surged over 56% year-to-date, driven by strong Q1 earnings that beat analyst expectations. The company offers consistent profitability, revenue growth, and an attractive forward P/E ratio of just over 12.

Rubrik Q2 Adj. EPS $0.22 Beats $0.04 Estimate, Sales $427.260M Beat $396.278M Estimate

Rubrik (NYSE:RBRK) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.04 by 450 percent. This is a 833.33 percent increase over losses of $(0.03) per share from the same

PagerDuty Sees Q3 Adj EPS $0.34-$0.36 vs $0.34 Est; Sees Sales $123.000M-$125.000M vs $124.255M Est

PagerDuty (NYSE:PD) is looking for Q3 Adj EPS of $0.34-$0.36 vs $0.34 analyst estimate. sees sales of $123.000 million-$125.000 million vs $124.255 million analyst estimate.

Alerus Financial Announces Buyback Program Of Up To 1,250,000 Shares

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000903419/000143774926029099/alrs20260825_8k.htm

Kazia Therapeutics Commences Offering Of American Depositary Shares; Terms Undisclosed

Kazia Therapeutics Limited (NASDAQ:KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity

Elastic shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance above estimates. Also, the company raised its FY27 guidance.

Rubrik Raises FY2027 Adj EPS Guidance from $0.25-$0.35 to $0.47-$0.53 vs $0.31 Est; Raises FY2027 Sales Guidance from $1.638B-$1.648B to $1.685B-$1.693B vs $1.645B Est

Rubrik (NYSE:RBRK) raises FY2027 Adj EPS guidance from $0.25-$0.35 to $0.47-$0.53 vs $0.31 analyst estimate. Raises FY2027 sales outlook from $1.638 billion-$1.648 billion to $1.685 billion-$1.693 billion vs $1.645

Iris Energy Q4 Sales $137.200M Miss $142.320M Estimate

Iris Energy (NASDAQ:IREN) reported quarterly sales of $137.200 million which missed the analyst consensus estimate of $142.320 million by 3.60 percent. This is a 26.75 percent decrease over sales of $187.300 million

Workday shares are trading lower after the company reported Q2 financial results and cut its FY27 sales guidance below estimates. Also, the company issued Q3 sales guidance below estimates.

Rubrik Sees Q3 Adj EPS $0.07-$0.09 vs $0.06 Est; Sees Sales $429.000M-$431.000M vs $418.285M Est

Rubrik (NYSE:RBRK) is looking for Q3 Adj EPS of $0.07-$0.09 vs $0.06 analyst estimate. sees sales of $429.000 million-$431.000 million vs $418.285 million analyst estimate.

Autodesk shares are trading lower after the company reported Q2 financial results and issued Q3 EPS guidance below estimates. Also, the company narrowed its FY27 adjusted EPS guidance with its midpoint below estimates.

SentinelOne Lowers FY2027 Adj EPS Guidance from $0.32-$0.38 to $0.30-$0.32 vs $0.35 Est; Raises FY2027 Sales Guidance from $1.195B-$1.205B to $1.202B-$1.207B vs $1.205B Est

SentinelOne (NYSE:S) lowers FY2027 Adj EPS guidance from $0.32-$0.38 to $0.30-$0.32 vs $0.35 analyst estimate. Raises FY2027 sales outlook from $1.195 billion-$1.205 billion to $1.202 billion-$1.207 billion vs $1.205

Workday Board Authorizes Open-Ended Repurchase of Up to An Additional $4B of Its Outstanding Shares Of Class A Common Stock

Workday welcomed new customers including BWX Technologies, Inc., Guess, KPMG LLP, and S-E-B, and expanded existing relationships with Caterpillar, Delivery Hero (Talibat), Lithia & Driveway, Merck & Co., Inc.,

Pasqal Completes Business Combination With Bleichroeder Acquisition Corp. II, To Begin Nasdaq Trading As “PSQL” Aug. 28

Pasqal Holding SA expects its ordinary shares to begin trading on Nasdaq under the ticker symbol "PSQL" on August 28thTransaction establishes a strong capital foundation for Pasqal as a public company, with

SentinelOne Sees Q3 Adj EPS $0.08-$0.09 vs $0.11 Est; Sees Sales $309.000M-$311.000M vs $309.442M Est

SentinelOne (NYSE:S) is looking for Q3 Adj EPS of $0.08-$0.09 vs $0.11 analyst estimate. sees sales of $309.000 million-$311.000 million vs $309.442 million analyst estimate.

Alto Neuroscience Promotes Nick Smith To President, CFO, Effective Aug. 26

Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company developing novel precision medicines for neuropsychiatric disorders, today announced the promotion of Nick Smith to president and chief

Elastic Raises FY2027 Adj EPS Guidance from $3.21-$3.29 to $3.29-$3.37 vs $3.24 Est; Raises FY2027 Sales Guidance from $1.985B-$2.000B to $1.998B-$2.010B vs $1.993B Est

Elastic (NYSE:ESTC) raises FY2027 Adj EPS guidance from $3.21-$3.29 to $3.29-$3.37 vs $3.24 analyst estimate. Raises FY2027 sales outlook from $1.985 billion-$2.000 billion to $1.998 billion-$2.010 billion vs $1.993

Marvell Tech Sees Q3 GAAP EPS $0.48-$0.58 vs $0.52 Est

Marvell Tech (NASDAQ:MRVL) is looking for Q3 GAAP EPS of $0.48-$0.58 vs $0.52 analyst estimate.

ICF Selected For $20M Recompete Contract To Continue Serving As Lead Implementer For Energy Efficiency Contract Supporting Consortium Of Northeast Utilities And Service Providers

Improving Energy Affordability for Customers Through Efficiency and InnovationRESTON, Va., Aug. 27, 2026 /PRNewswire/ -- ICF (NASDAQ:ICFI), a leading global solutions and technology provider, was recently selected for a

Marvell Tech Sees Q3 Adj EPS $1.05-$1.15 vs $1.07 Est; Sees Sales $2.993B-$3.308B vs $3.034B Est

Marvell Tech (NASDAQ:MRVL) is looking for Q3 Adj EPS of $1.05-$1.15 vs $1.07 analyst estimate. sees sales of $2.993 billion-$3.308 billion vs $3.034 billion analyst estimate.

Key Tronic Says Due To Uncertainty In Timing Of New Program Ramps And Continued Macroeconomic Uncertainty, Will Not Be Issuing Revenue Or Earnings Guidance For Q1 FY27

Business OutlookDue to uncertainty in the timing of new program ramps and continued macroeconomic uncertainty, Key Tronic will not be issuing revenue or earnings guidance for the first quarter of fiscal year 2027.

Elastic Sees Q2 Adj EPS $0.80-$0.82 vs $0.80 Est; Sees Sales $486.000M-$487.000M vs $483.397M Est

Elastic (NYSE:ESTC) is looking for Q2 Adj EPS of $0.80-$0.82 vs $0.80 analyst estimate. sees sales of $486.000 million-$487.000 million vs $483.397 million analyst estimate.

EastGroup Properties Raises Quarterly Dividend From $1.55 To $1.75/Share

Parsons Awarded ME3 Region And Africa 2 Region Task Orders Under U.S. DOE NNSA’s Counter Nuclear Smuggling Systems Deployment Contract

Parsons secured two new NNSA CNSSD task orders for design and deployment of counter-nuclear smuggling systems across the Middle East and Africa.The awards bring Parsons' total CNSSD portfolio to seven task orders

Elastic Q1 Adj. EPS $0.70 Beats $0.58 Estimate, Sales $478.113M Beat $469.745M Estimate

Lam Research Increases Its Quarterly Dividend From $0.26 To $0.33 Per Share

Lam Research Corporation (NASDAQ:LRCX) today announced that its Board of Directors has approved a $0.07, or 27%, increase in its quarterly dividend, from $0.26 to $0.33 per share of common stock. The dividend payment

Outlook Therapeutics Announces Appointment Of Kevin Lundquist As CFO Effective September 1

Rivian Automotive CFO Claire McDonough Decides To Step Down, Effective Oct. 30

Rivian Automotive, Inc. (NASDAQ: RIVN) today announced that Chief Financial Officer Claire McDonough has decided to step down from her role to pursue a new opportunity and relocate to the East Coast to be closer to her

Marvell Tech Q2 Adj. EPS $0.94 Beats $0.92 Estimate, Sales $2.739B Beat $2.710B Estimate

PagerDuty Q2 Adj. EPS $0.32 Beats $0.31 Estimate, Sales $124.436M Beat $123.013M Estimate

PagerDuty (NYSE:PD) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.31 by 3.23 percent. This is a 6.67 percent increase over earnings of $0.30 per share from the same

Ulta Beauty Raises FY2026 GAAP EPS Guidance from $28.36-$28.80 to $28.70-$29.00 vs $28.94 Est; Raises FY2026 Sales Guidance from $13.136B-$13.260B to $13.223B-$13.285B vs $13.209B Est

Ulta Beauty (NASDAQ:ULTA) raises FY2026 GAAP EPS guidance from $28.36-$28.80 to $28.70-$29.00 vs $28.94 analyst estimate. Raises FY2026 sales outlook from $13.136 billion-$13.260 billion to $13.223 billion-$13.285

SentinelOne Q2 Adj. EPS $0.08 Beats $0.07 Estimate, Sales $291.981M Beat $290.250M Estimate

SentinelOne (NYSE:S) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.07 by 14.29 percent. This is a 100 percent increase over earnings of $0.04 per share from the same

Workday Sees Q3 Sales $2.515B vs $2.697B Est

Workday (NASDAQ:WDAY) sees Q3 sales of $2.515 billion vs $2.697 billion analyst estimate.

Workday Lowers FY2027 Sales Guidance from $10.635B-$10.660B to $9.940B-$9.950B vs $10.669B Est

Workday (NASDAQ:WDAY) lowers FY2027 sales outlook from $10.635 billion-$10.660 billion to $9.940 billion-$9.950 billion vs $10.669 billion estimate.

Lifevantage Q4 Adj. EPS $0.11 Misses $0.13 Estimate, Sales $42.377M Miss $45.949M Estimate

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.13 by 15.38 percent. This is a 35.29 percent decrease over earnings of $0.17 per share from the

Ulta Beauty Q2 EPS $6.55 Beats $6.16 Estimate, Sales $3.036B Beat $2.955B Estimate

Ulta Beauty (NASDAQ:ULTA) reported quarterly earnings of $6.55 per share which beat the analyst consensus estimate of $6.16 by 6.33 percent. This is a 13.32 percent increase over earnings of $5.78 per share from the

Scholastic Announces Repurchase Of 289,624 Common Shares From Estate Of Former CEO Richard Robinson For $11.5M At $39.7603/Share

Kazia Therapeutics Says Paxalisib Phase 1b Data In Six Evaluable Stage IV Triple-Negative Breast Cancer Patients Showed 83% Objective Response Rate, No Treatment-Related Serious Adverse Events

Autodesk Narrows FY2027 Adj EPS Guidance from $12.40-$12.65 to $12.52-$12.60 vs $12.60 Est; Raises FY2027 Sales Guidance from $8.155B-$8.215B to $8.575B-$8.650B vs $8.206B Est

Autodesk (NASDAQ:ADSK) narrows FY2027 Adj EPS guidance from $12.40-$12.65 to $12.52-$12.60 vs $12.60 analyst estimate. Raises FY2027 sales outlook from $8.155 billion-$8.215 billion to $8.575 billion-$8.650 billion vs

Key Tronic Q4 Adj. EPS $(0.26) Up From $(0.35) YoY, Sales $102.027M Down From $110.500M YoY

Key Tronic (NASDAQ:KTCC) reported quarterly losses of $(0.26) per share. This is a 25.71 percent increase over losses of $(0.35) per share from the same period last year. The company reported $102.027 million in sales

Autodesk Widens FY2027 GAAP EPS Guidance from $8.07-$8.63 to $7.89-$8.72 vs $8.44 Est

Autodesk (NASDAQ:ADSK) widens FY2027 GAAP EPS guidance from $8.07-$8.63 to $7.89-$8.72 vs $8.44 analyst estimate..

Autodesk Sees Q3 Adj EPS $3.04-$3.09 vs $3.14 Est; Sees Sales $2.125B-$2.140B vs $2.082B Est

Autodesk (NASDAQ:ADSK) is looking for Q3 Adj EPS of $3.04-$3.09 vs $3.14 analyst estimate. sees sales of $2.125 billion-$2.140 billion vs $2.082 billion analyst estimate.